Regulatory brief
TGA Peptide Watchlist Australia
Plain-English summary of the TGA's 2026 unapproved peptide warning, including BPC-157, GHK-Cu, TB-500, retatrutide, CJC-1295, labelling, import, and advertising risk.
Read briefRegulatory index
The regulatory layer buyers search before they trust a peptide vendor.
These pages turn official TGA and ABF records into plain-English buyer checks. They do not replace legal or medical advice. They make the visible risk surface easier to inspect before payment.
Regulatory brief
GLP-1 Compounding Ban Australia 2024
What the Australian GLP-1 pharmacy compounding change means for peptide buyers comparing semaglutide, tirzepatide, retatrutide, online clinics, and supplier claims.
Read briefRegulatory brief
Peptide Customs Seizure Australia
How to read Australian customs and import-risk signals before trusting overseas peptide dispatch, code-only labels, research-use disclaimers, and unclear shipping routes.
Read briefRegulatory brief
TGA Peptide and Compounding Enforcement Actions
Evidence-led index of TGA enforcement actions relevant to peptide, GLP-1, compounding, import, advertising, and grey-market supplier risk in Australia.
Read briefRegulatory brief
Personal Importation Scheme Peptides Australia 2026
What Australian peptide buyers misunderstand about the Personal Importation Scheme, prescription-only medicines, 3-month supply limits, counterfeit products, labels, and seizure risk.
Read briefRegulatory brief
Australian Peptide Scheduling Map
A source-backed map of Australian peptide scheduling signals for BPC-157, TB-500, CJC-1295, GHRPs, GHSs, Ipamorelin, Hexarelin, Melanotan II, GHK-Cu, retatrutide, and related searches.
Read briefRegulatory brief
TGA Peptide Enforcement Tracker
Monthly Peptide Checker tracker of public TGA actions relevant to peptides, clinic advertising, compounded weight-loss medicines, import risk, and unapproved therapeutic goods.
Read briefRegulatory brief
Peptide Adverse Event Reporting Australia
How Australian peptide buyers should preserve evidence and use TGA adverse event reporting signals without treating every report as proof of causation.
Read briefRegulatory brief
ARTG Approved Peptide Medicines Australia
How to check an AUST number, sponsor, active ingredient, dosage form, and ARTG public summary before trusting peptide approval claims in Australia.
Read briefRegulatory brief
Peptide Advertising Claims Australia
How Australian peptide buyers can read vendor claims against TGA advertising rules, prescription-medicine restrictions, therapeutic-use language, testimonials, and influencer codes.
Read briefRegulatory brief
Peptide Sciences Shutdown Australia Search Guide
Why Australian buyers searching Peptide Sciences shutdown, refund, alternatives, or scam questions should verify replacement vendors before ordering.
Read briefRegulatory pages should feed the vendor rubric without turning adjacent enforcement into unproven accusations against a specific supplier.
Read the scoring method